Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
about
Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationReduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitusLiver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDLGut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerUptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosisAbsence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IICD36: implications in cardiovascular diseasebeta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteinsAssociation between monocyte Fcgamma subclass expression and acute coronary syndromeExtracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular InflammationMacrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome AnalysisPotential Anti-Atherosclerotic Properties of AstaxanthinMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisMIF and CXCL12 in Cardiovascular Diseases: Functional Differences and SimilaritiesThe Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary SyndromesHyperlipidemia, tissue factor, coagulation, and simvastatinTumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesRegulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion developmentThe innate immune response to products of phospholipid peroxidationOxidation by neutrophils-derived HOCl increases immunogenicity of proteins by converting them into ligands of several endocytic receptors involved in antigen uptake by dendritic cells and macrophages"Eat me" imaging and therapyCD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationThe fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activitiesCirculating CD36 is reduced in HNF1A-MODY carriersCD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsCD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosisMacrophages in the pathogenesis of atherosclerosisRegulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.Nuclear receptors as drug targets for metabolic disease.Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1.Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation.CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.Microarray gene profiling of laser-captured cells: a new tool to study atherosclerosis in mice.Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism.Quantitative and qualitative methods using fluorescence microscopy for the study of modified low density lipoproteins uptake.Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.A review of plant-based compounds and medicinal plants effective on atherosclerosis.CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.
P2860
0a2f33cf6344e041e6a6ca1c2b306d2ab0b98f5f68dbf2d603b949b26fe24f06b7b4e6798ff36d758ce1378b6e289f6fca05a94f995b6400a43228aaab90b0f958cda1f7829a4a348d23cd91790f9386b0a8df5c0cf81184e3b9ae7b141c3df8c2ac675bba08d506c030385b1bbf1d6dd8caad73ef18037fe392b0649e6cfc0728cf8ab756d11832bdae708cf8bc5b3be229209c4a5e916b1f8fb70179439936
P248
Q21558503-31708B3B-34A0-4A9A-A9E8-99D3A93F4832Q24314471-6F28B9EE-3CF0-4BE9-B8F5-0E183FA972B5Q24337296-E6E5220D-CA01-4902-A105-3164C432DBE4Q24601951-C4CA745D-934A-4509-871B-8B60F78C9C94Q24642646-9D962D34-53F8-4876-83AF-9B5171BE51ECQ24652179-54605A62-60B4-4FBB-8E20-B0F78A9BCD5CQ24658096-84EE23E4-845B-402F-9AC8-0D58CAB8BF02Q24678338-37272A75-6844-4427-8107-1965011CEB0CQ24803005-E7234265-1E35-45B3-BE51-C754363506B0Q24804925-E3390655-467D-4169-9956-1C71B124FDE9Q26738276-358D2A3C-7F5D-4F28-9F61-AABEC799C109Q26738772-ACA5F456-EDAB-46B4-91D3-4A79FCE22C84Q26767224-DA612829-03FB-4792-949E-ECC7EF36B60AQ26780531-0A9A0C83-3EB4-45D7-A7D4-4579D633FF83Q26800135-A113DB60-A0BF-4F9D-903F-9040697031BCQ26852646-5E4E9DF3-CE2F-4203-8E6C-44D96D71610DQ27024964-6DF4CF51-E4ED-43BB-88B2-0E1F499FE988Q28219857-7097D2FD-8D33-4C92-8C5F-306501DF92A0Q28260242-74D0BA73-4FE5-4D8B-8D37-E411E4EEB989Q28389385-EBF70D94-2976-46AE-8E47-49B9DC345C51Q28391399-83ACDE67-21EE-45B2-92AE-8BFD7071379DQ28394148-72E290F8-454E-454E-809D-60C9FCFC2C34Q28506984-3AB3D88D-878C-4BD8-ABDA-D16E9EC20D23Q28513582-4FE4EC53-3F63-4D4F-88B1-B9FC6C628A5AQ28533348-7F700177-FC3E-460B-91BC-C5322FAC9791Q28580132-9223231C-D0D1-44D6-9572-9241BF02A492Q28729175-F9F13BE1-E2BC-4964-B76B-541D31E31CBAQ29617765-0C877D83-3B37-484C-B472-8F96ECE302A4Q30275422-749F1360-45BD-4B2D-A5DF-B7C78298C230Q30430126-BFCE23A0-33DD-497A-9250-1C695E17E562Q30436299-7E061697-B6F4-4092-8910-BDB15F7CEDFDQ30438268-5F8DE6FC-7EE7-47C2-A0BC-A33DA2A9B1DEQ30440560-17F75443-86DB-4DCF-AC51-21BB9B0482AFQ30557430-1298DF42-4B6D-47D3-B0F9-668D03D1D7C4Q33320713-833242CF-7612-429F-800D-F9EF77DAF736Q33387961-3E1E7618-905A-4E15-9850-1C1F00EE99A0Q33505358-C51AD692-0292-49F5-A0F9-7EC4E8097273Q33547771-A660E5BA-A519-48B0-842A-87005C94BF48Q33561027-E6034E0E-5101-43F5-AD97-F28585EA2704Q33609100-A2F0BC11-6364-4E37-B65B-9C3297D2503E
P2860
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@ast
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en-gb
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@nl
type
label
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@ast
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en-gb
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@nl
prefLabel
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@ast
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en-gb
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@nl
P2093
P921
P3181
P356
P1476
Scavenger receptors class A-I/ ...... o lipid loading in macrophages
@en
P2093
Eugene A Podrez
Henry F Hoff
Jeongmi S Rhee
Lorna Andersson
Maria Febbraio
Mason W Freeman
Roy Silverstein
Stephanie Koehn
Vidya V Kunjathoor
P304
49982-49988
P3181
P356
10.1074/JBC.M209649200
P407
P577
2002-10-09T00:00:00Z